These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25738815)

  • 1. Laboratory investigations of vaccinated patients with varicella.
    Siedler A; Dettmann M; Tolksdorf K; Polte C; Walter C; Ehlers B
    Vaccine; 2015 Apr; 33(16):1968-73. PubMed ID: 25738815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis and characteristics of breakthrough varicella in children.
    Weinmann S; Chun C; Mullooly JP; Riedlinger K; Houston H; Loparev VN; Schmid DS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S132-8. PubMed ID: 18419386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in confirming a varicella outbreak in the two-dose vaccine era.
    Mahamud A; Wiseman R; Grytdal S; Basham C; Asghar J; Dang T; Leung J; Lopez A; Schmid DS; Bialek SR
    Vaccine; 2012 Nov; 30(48):6935-9. PubMed ID: 22884663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of varicella after implementation of routine childhood varicella vaccination in Germany.
    Spackova M; Muehlen M; Siedler A
    Pediatr Infect Dis J; 2010 Sep; 29(9):884-6. PubMed ID: 20442685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).
    Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J
    Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of vaccine-induced immunity to varicella over time.
    Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
    N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness over time of varicella vaccine.
    Vázquez M; LaRussa PS; Gershon AA; Niccolai LM; Muehlenbein CE; Steinberg SP; Shapiro ED
    JAMA; 2004 Feb; 291(7):851-5. PubMed ID: 14970064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of varicella vaccination in children in Germany: a case-control study.
    Liese JG; Cohen C; Rack A; Pirzer K; Eber S; Blum M; Greenberg M; Streng A
    Pediatr Infect Dis J; 2013 Sep; 32(9):998-1004. PubMed ID: 23694831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contagiousness of varicella in vaccinated cases: a household contact study.
    Seward JF; Zhang JX; Maupin TJ; Mascola L; Jumaan AO
    JAMA; 2004 Aug; 292(6):704-8. PubMed ID: 15304467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.